Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Aug 2026 for XERIS BIOPHARMA HOLDINGS INC, €145k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Steven Pieper: trading record in brief
Steven Pieper appears in our data through filings on Xeris Biopharma Holdings, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 6 July 2026 and the latest from 12 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 12 August 2026: a transaction of €145k, in Xeris Biopharma Holdings, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Steven Pieper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
20,000 shares@ US$8.39CommonSEC144:0001950047-26-008033
27,600 shares@ US$8.370.016% mcap61.6% of flowCommonSEC144:0001950047-26-006941
17,400 shares@ US$8.280.010% mcap38.4% of flowCommonSEC144:0001950047-26-006884
3 of 3 declarations
